These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20953652)

  • 21. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
    Papadimitriou-Olivgeris M; Kolonitsiou F; Zerva L; Lebessi E; Koutsia C; Drougka E; Sarrou S; Giormezis N; Vourli S; Doudoulakakis A; Konsolakis C; Marangos M; Anastassiou ED; Petinaki E; Spiliopoulou I
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):386-8. PubMed ID: 26341703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci.
    Kolar M; Urbanek K; Vagnerova I; Koukalova D
    J Clin Pharm Ther; 2006 Feb; 31(1):67-72. PubMed ID: 16476122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
    Michel M; Gutmann L
    Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.
    Calfee DP
    Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002.
    Arias CA; Reyes J; Zúñiga M; Cortés L; Cruz C; Rico CL; Panesso D;
    J Antimicrob Chemother; 2003 Jan; 51(1):59-68. PubMed ID: 12493788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of resistant gram-positive pathogens in the surgical patient.
    Rapp RP
    Surg Infect (Larchmt); 2000; 1(1):39-47. PubMed ID: 12594908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
    Snydman DR; McDermott LA; Jacobus NV
    J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 38. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB; ;
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):249-60. PubMed ID: 17326014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Lai KK; Fontecchio S; Melvin Z; Baker SP
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1018-24. PubMed ID: 17006807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
    Altunsoy A; Aypak C; Azap A; Ergönül Ö; Balık I
    Int J Med Sci; 2011; 8(4):339-44. PubMed ID: 21647326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.